Anti tubercular drugs according to dots for 79 year female in individual tablets
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
The library doesn't have detailed DOTS individual tablet dosing tables, so I'll answer from current WHO/RNTCP guidelines directly.
DOTS Regimen for TB — 79-year-old Female (Individual Tablets)
Weight-band consideration
At 79 years, body weight must be assessed first. The standard DOTS regimen is the same regardless of age, but dose is weight-based.
Standard New TB Case Regimen (Category I / Ds-TB)
2HRZE / 4HR
- Intensive Phase: 2 months — Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E)
- Continuation Phase: 4 months — Isoniazid (H) + Rifampicin (R)
Individual Tablet Doses (Daily, as per RNTCP/WHO weight bands)
| Drug | Tablet Strength | 25–34 kg | 35–49 kg | 50–69 kg | ≥70 kg |
|---|---|---|---|---|---|
| Isoniazid (H) | 300 mg | 1 | 1 | 1.5 | 2 |
| Rifampicin (R) | 150 mg | 2 | 3 | 3 | 4 |
| Pyrazinamide (Z) | 500 mg | 1.5 | 2 | 3 | 4 |
| Ethambutol (E) | 400 mg | 2 | 3 | 3 | 4 |
Dosing is given daily under direct observation in the DOTS programme.
Special Considerations for a 79-year-old Female
| Concern | Detail |
|---|---|
| Hepatotoxicity risk | Higher in elderly — monitor LFTs baseline and monthly (Pyrazinamide > Rifampicin > Isoniazid) |
| Peripheral neuropathy | Isoniazid can cause neuropathy — Pyridoxine (Vitamin B6) 25–40 mg/day is mandatory in elderly |
| Ocular toxicity | Ethambutol — baseline visual acuity + colour vision testing; monitor monthly. Consider dose reduction at ≥60 years (15 mg/kg instead of 25 mg/kg) |
| Drug interactions | Rifampicin is a strong CYP450 inducer — review all concurrent medications (anticoagulants, antidiabetics, antihypertensives) |
| Renal function | Adjust Ethambutol if CrCl <30 mL/min (ethambutol is renally cleared) |
| Bone density | Anti-TB drugs (especially Rifampicin) can worsen osteoporosis — consider calcium/Vitamin D supplementation |
Pyridoxine Supplementation
Pyridoxine (B6) 25 mg once daily — given alongside the regimen throughout treatment to prevent INH-induced peripheral neuropathy (high priority in elderly patients).
Summary for a Typical 50–69 kg Patient (Most Common Weight Band)
Intensive Phase (Daily × 2 months):
- Isoniazid 300 mg — 1.5 tabs (or use 450 mg = 1½ tab)
- Rifampicin 150 mg — 3 tabs
- Pyrazinamide 500 mg — 3 tabs
- Ethambutol 400 mg — 3 tabs
- Pyridoxine 25 mg — 1 tab
Continuation Phase (Daily × 4 months):
- Isoniazid 300 mg — 1.5 tabs
- Rifampicin 150 mg — 3 tabs
- Pyridoxine 25 mg — 1 tab
Note: Fixed-dose combinations (FDCs) are preferred in standard DOTS, but individual tablets are used when FDCs are contraindicated (e.g., hepatic disease, adverse effects requiring omission of one drug, or drug-resistant patterns requiring regimen modification). In elderly patients with multiple comorbidities, individual tablets allow flexibility in dose adjustment and drug omission if needed.
This is a shared conversation. Sign in to Orris to start your own chat.